Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1 A Randomized Clinical Trial in Diverse Multinational Settings 英文参考文献.docVIP

下载本文档

6
0
约8.36万字
约 16页
2017-05-11 发布于上海
举报
版权申诉

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1 A Randomized Clinical Trial in Diverse Multinational Settings 英文参考文献.doc

1、本文档共16页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1 A Randomized Clinical Trial in Diverse Multinational Settings 英文参考文献

EfficacyandSafetyofThreeAntiretroviralRegimensfor InitialTreatmentofHIV-1:ARandomizedClinicalTrialin DiverseMultinationalSettings ThomasB.Campbell1*,LauraM.Smeaton2,N.Kumarasamy3,TimothyFlanigan4,KarinL.Klingman5, CynthiaFirnhaber6,BeatrizGrinsztejn7,MinaC.Hosseinipour8,JohnstoneKumwenda9,UmeshLalloo10, CynthiaRiviere11,JorgeSanchez12,MarineideMelo13,KhuanchaiSupparatpinyo14,SrikanthTripathy15, AnaI.Martinez5,ApsaraNair16,AnnWalawander16,LauraMoran17,YunChen2,WendySnowden18, JamesF.Rooney19,JonathanUy20,RobertT.Schooley21,VictorDeGruttola2,JamesGitaHakim22 thePEARLSstudyteamoftheACTG for 1DivisionofInfectiousDiseases,DepartmentofMedicine,UniversityofColoradoSchoolofMedicine,Aurora,UnitedStatesofAmerica,2CenterforBiostatisticsinAIDS Research,HarvardSchoolofPublicHealth,Boston,Massachusetts,UnitedStatesofAmerica,3YRGCentreforAIDSResearchEducation,Chennai,India,4BrownMedical School,Providence,RhodeIsland,UnitedStatesofAmerica,5NationalInstitutesofHealth,Bethesda,Maryland,UnitedStatesofAmerica,6ClinicalHIVResearchUnit, DepartmentofMedicine,FacultyofHealthSciences,UniversityoftheWitwatersrand,Johannesburg,SouthAfrica,7EvandroChagasClinicalResearchInstitute,Fiocruz, RiodeJaneiro,Brazil,8KamuzuCentralHospital,Lilongwe,Malawi,9DepartmentofMedicine,CollegeofMedicine,Blantyre,Malawi,10NelsonR.MandelaSchoolof Medicine,Durban,South Africa, 11Institut Nacionalde laboratoire et de Recherches, Port-au-Prince, Haiti, 12Asociacio′nCivil Impacta Salud yEducacio′n,Lima, Peru, 13ServicodeInfectology,HospitalNossaSenhoradaConceicao-GHC,PortoAlegre,Brazil,14DepartmentofMedicineandResearchInstituteforHealthSciences,Chiang MaiUniversity,ChiangMai,Thailand,15NationalAIDSResearchInstitute,Pune,India,16FrontierScienceTechnologyResearchFoundation,Amherst,Massachusetts, UnitedStatesofAmerica,17SocialScientificSystems,Inc,SilverSpring,Maryland,UnitedStatesofAmerica,18GlaxoSmithKline,ResearchTrianglePark,NorthCarolina, United States ofAmerica, 19Gilead Sciences, Inc., Foster City, California,